We use cookies to give you a better Web experience. By visiting our website you agree to our use of cookies. Read about cookies
OK
  1. Home
  2. Mandates
  3. Vinge advises Bridgepoint in conjunction with its investment in Vitamin Well

Mandate Vinge advises Bridgepoint in conjunction with its investment in Vitamin Well

November 29, 2016

Vinge has advised Bridgepoint Development Capital in conjunction with its investment in Vitamin Well AB. Vitamin Well AB is a leading Nordic company within functional drinks, which develops, markets and sells high-quality drinks under the well-known trademarks Vitamin Well, Vitamin Well Free, NOBE aloe vera, NOCCO and the sports drink Vitamin Well+.

Following its formation in 2006, Vitamin Well AB has had the vision of being the best and the tastiest functional drinks manufacturer, adapted for various different target groups and situations. Vitamin Well has its headquarters in Stockholm, employs 84 persons and its drinks are sold in 28 countries. The transaction is conditional upon approval from the Swedish Competition Authority.

Vinge’s team consists of partner Daniel Rosvall together with, among others, associates Samra Baytar and Ilze Lukins (M&A), Tomas Forsgren (intellectual property), Lisa Sennerby (employment), Kristoffer Larson (real estate), Albert Wållgren and Karl Klackenberg (banking & finance) and counsel Johan Cederblad (regulatory issues). Grant McKelvey and Marita Ljunggren are advising on competition law notification issues.

 

Clarification of the interpretation of ”nearest suitable railway station”

 Road transport performed by Samskip Sia in Sweden has been confirmed to be within the framework of a permitted combined transport through a decision of the Administrative court of Falun in Sweden. The central question in the case was how to interpret the term “nearest suitable railway station”
June 30, 2020

DAC 6 – EU Directive concerning reportable cross‑border tax arrangements

 DAC 6 is a EU Directive which entails that advisers are subject to a duty to notify the relevant tax authorities concerning their client’s cross‑border arrangements. The purpose of the information disclosure obligation is to combat tax evasion, tax fraud and tax avoidance.
June 04, 2020

The importance of continuous focus on compliance procedures in disrupting times

 A large number of corporations will most certainly be severely impacted by the effects of the Covid-19 pandemic. The new challenges will impact companies’ compliance risks, which are likely to be different and, to a certain extent, increased. It is crucial that - also in disrupting times - internal compliance procedures are maintained and that new risks are identified and mitigated.
May 28, 2020